Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07648043
EARLY_PHASE1

Feasibilty and Acceptability of Amani

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

Adults with sickle cell disease (SCD) experience severe pain, emotional distress, and social isolation that diminish their quality of life. This project will test Amani, a novel virtual reality supportive care intervention designed to improve coping skills and strengthen peer support. If feasible and acceptable, Amani offers an accessible digital supportive care intervention to improve psychological well-being and quality of life among individuals living with SCD and potentially other chronic illnesses.

Official title: Feasibilty and Acceptability of Amani, a Virtual Reality Application for Adults With Sickle Cell Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2027-01-01

Completion Date

2028-04-30

Last Updated

2026-06-15

Healthy Volunteers

No

Interventions

BEHAVIORAL

Amani

Amani is a multi-component VR supportive care intervention specifically tailored for adults with SCD. Amani integrates mindfulness-based pain management exercises, psychoeducational modules to build adaptive coping strategies, and facilitated VR group sessions to reduce isolation and foster peer support.

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States